BERLIN (Reuters) – Siemens Healthineers confirmed its full-year outlook on Thursday despite a drop in quarterly profit driven by low…
Roche warns 2023 profits will fall on $5 billion COVID sales hit
By Ludwig Burger BASEL (Reuters) – Roche warned on Thursday profits will decline in 2023 as falling demand for its…
Japan’s Takeda’s profit slips 13%, pipeline bolsters outlook
TOKYO (Reuters) – Japan’s Takeda Pharmaceutical Co posted a 13% drop in operating earnings for the nine months ended December…
GSK gives few clues on plans to replenish medicine cabinet
By Natalie Grover and Maggie Fick LONDON (Reuters) -GSK chief executive Emma Walmsley on Wednesday made replenishing the drugmaker’s pipeline…
AbbVie’s Humira gets a U.S. rival, but costs could stay high
By Patrick Wingrove (Reuters) – U.S. patients will finally get access to cheaper versions of AbbVie Inc’s blockbuster arthritis drug…
Novartis says operating profit to grow again ahead of Sandoz spin-off
By Ludwig Burger BASEL (Reuters) – Novartis on Wednesday predicted that core operating income would grow in a “mid single…
Amgen revenue falls slightly as Lilly COVID deal contributes less
By Sriparna Roy and Michael Erman (Reuters) -Amgen Inc on Tuesday said its fourth-quarter revenue fell slightly as a 4%…
Pfizer sees steep 2023 fall in COVID sales, aims to bolster pipeline
By Bhanvi Satija and Michael Erman (Reuters) – Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its…
Bayer under investor pressure to speed up CEO changeover
By Patricia Weiss and Ludwig Burger FRANKFURT (Reuters) – A top-10 shareholder in Bayer on Tuesday called on the group’s…
Drugmakers prevail in dispute over U.S. discount drug program
By Brendan Pierson (Reuters) -Drug manufacturers can limit healthcare providers’ use of outside pharmacies for dispensing drugs under a federal…